OncoPrecision is a platform therapeutics company integrating patient-derived high-throughput biology with AI/ML to develop a pipeline of antibody-drug conjugates (ADCs) and bispecific antibodies, to target areas of high unmet medical need — primarily in oncology. Our clinically validated platform enhances the probability of success across drug discovery and development by generating robust translational human data before entering the clinic. Our company spun out of Dr. Gastón Soria’s Synthetic Lethality in Cancer Lab with a strong track record of successful drug discovery collaborations with leading global pharmaceutical companies. We are pioneering a patient-centric paradigm shift in the way transformational drugs are discovered and developed.
Company Details
- Employees
- 24
- Founded
- -
- Address
- 180 Varick St,
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://oncoprecision.bio
- HQ
- New York
Oncoprecision Questions
Oncoprecision's website is http://oncoprecision.bio
Oncoprecision's LinkedIn profile is https://www.linkedin.com/company/oncoprecision
Oncoprecision has
24 employees.
View email and phone details for 24
employees at Oncoprecision.
Oncoprecision's industry is
Biotechnology Research
Oncoprecision's top competitors are
Argenbio,
Oncoliq,
Beeflow,
Bitgenia,
Loci Labs,
Puna Bio,
Caspr Biotech,
Oncoprecision Chile,
Stämm,
Michroma.
Oncoprecision's categories are Biotechnology Research
Oncoprecision's founding year is 2020
